Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.50
-0.02 (-0.36%)
At close: Jan 7, 2026, 4:00 PM EST
5.62
+0.12 (2.18%)
After-hours: Jan 7, 2026, 5:42 PM EST
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $703.26 million as of January 7, 2026. Its market cap has decreased by -11.80% in one year.
Market Cap
703.26M
Enterprise Value
470.18M
1-Year Change
-11.80%
Ranking
Category
Stock Price
$5.50
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $703.26M, a decrease of -68.89%. That is a compound annual growth rate of -23.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 703.26M | 8.91% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |